8-K: VERSES AI Secures CAD$14M Financing, Issues Warrants

VERSES AI Inc. has closed a non-brokered private placement with Sorbie Bornholm LP and Sorbie Investments LLP, securing a notional CAD$14 million through units of shares and warrants, with initial proceeds of CAD$700,000 received.

Summary

• VERSES AI Inc. closed a non-brokered private placement with Sorbie Bornholm LP (SBLP) and Sorbie Investments LLP (SILP).
• The company is expected to receive a notional aggregate of CAD$14,000,000.
• This financing involves the issuance of 2,333,334 units to SBLP and SILP at CAD$6.00 per unit, with each unit comprising one Class A Subordinate Voting Share and one-half warrant.
• Including units for finders fees, the total units issued in exchange for the notional CAD$14,000,000 amount to 2,660,000.
• An initial tranche of CAD$700,000 has been received, corresponding to 140,000 units.
• The remaining CAD$13,300,000 will be received in 11 monthly tranches, each notionally CAD$1,209,091.
• The actual amount received per monthly tranche will be adjusted based on the 20-day volume-weighted average price (VWAP) of the shares relative to a benchmark price of CAD$7.75.
• Warrants issued to SILP allow subscription for 616,667 Common Shares at CAD$7.00 per share, expiring November 6, 2028.
• The net proceeds are intended for working capital and general corporate purposes.

Sentiment

Score: 7

Explanation: The company successfully secured a significant notional financing amount, providing capital for operations. While the performance-linked tranches introduce some uncertainty regarding the final amount received, the overall transaction strengthens the company's financial position and indicates investor confidence in its long-term potential, despite the associated dilution and brokerage fees.

Positives

• Secured CAD$14,000,000 in notional financing, providing capital for operations.
• Initial CAD$700,000 received immediately, boosting liquidity.
• Potential for higher proceeds from monthly tranches if share price (20-day VWAP) exceeds the CAD$7.75 benchmark.
• The financing structure allows for ongoing capital infusion over 11 months.

Negatives

• Actual proceeds from monthly tranches can be less than the notional CAD$1,209,091 if the 20-day VWAP falls below CAD$7.75.
• Issuance of new shares and warrants will result in dilution for existing shareholders.
• An 8% brokerage fee is payable with each tranche, reducing net proceeds.
• The Benchmark Price can be increased under certain conditions (e.g., share placements below CAD$6.00, backdoor listings below CAD$6.00, or certain non-fixed price issuances), making it harder to exceed and receive more than the notional amount.
• Warrants are not exercisable if the holder would exceed 9.99% beneficial ownership, which could limit full exercise.

Risks

• Market Conditions: Fluctuations in share price could impact the actual proceeds received from the monthly tranches.
• Regulatory Approvals: Ongoing need for regulatory approvals for listing and trading.
• Timing of Payments: The timing of future tranches is subject to conditions and potential deferrals.
• Dilution: Issuance of new shares and potential exercise of warrants will dilute existing shareholder ownership.
• Resale Restrictions: Securities issued are subject to a statutory hold period of four months plus a day in Canada and U.S. Securities Act restrictions.
• Market Disruption Events: Could lead to postponement of valuation dates and settlement dates.
• Offer Period Event: A take-over bid could lead to deferral of settlement dates.
• MNPI Disclosure: Failure to promptly disclose material non-public information (MNPI) provided to Sorbie could lead to suspension of settlements or an Event of Default.
• Winding-Up Event: If a winding-up occurs during the exercise period, warrant holders are treated as if they fully exercised their rights, receiving a sum from surplus assets less the subscription price.

Future Outlook

The company anticipates receiving 11 additional monthly tranches, with the actual amounts dependent on the future trading performance of its shares relative to a CAD$7.75 benchmark. The net proceeds are intended to support working capital and general corporate purposes.

Management Comments

• "VERSES is a cognitive computing company building next-generation agentic software systems modeled after the wisdom and genius of Nature."
• "Designed around first principles found in science, physics and biology, our flagship product, Genius, is an agentic enterprise intelligence platform designed to generate reliable domain-specific predictions and decisions under uncertainty."
• "Imagine a Smarter World that elevates human potential through technology inspired by Nature." (Gabriel Rene, Founder & CEO)

Industry Context

This financing provides capital for a cognitive computing company, VERSES AI, which is developing agentic software systems. The structure, with performance-linked tranches, suggests a growth-stage company seeking flexible funding tied to market valuation, common in innovative tech sectors where traditional debt or fixed equity raises might be less suitable. The use of warrants and a sharing agreement indicates a strategic partnership with investors who are aligned with the company's long-term growth potential and share price appreciation.

Comparison to Industry Standards

• The CAD$6.00 unit price and CAD$7.00 warrant exercise price should be compared to recent trading prices of VERSES AI (not provided in filing, so cannot make specific comparison).
• The 8% brokerage fee is within a typical range for private placements, though on the higher side for larger institutional deals.
• The 'sharing arrangement' with performance-based tranches is a less common, more complex financing structure compared to standard equity raises or convertible notes, potentially reflecting specific investor demands or market conditions for a company in the AI/cognitive computing space.
• The 9.99% beneficial ownership cap for warrant exercise is a common regulatory measure to avoid triggering certain takeover bid rules or significant shareholder disclosure requirements.

Corporate Governance

Stakeholder Impact

• Shareholders: Experience dilution from the issuance of new shares and potential future warrant exercises. The performance-linked tranches introduce uncertainty regarding the total dilution and the effective price of future capital.
• Employees: The capital infusion provides financial stability, potentially supporting continued operations and growth initiatives.
• Customers: Enhanced financial stability may support continued product development and service delivery.
• Creditors: Improved liquidity from the financing could reduce credit risk.
• Investors (Sorbie): Gain equity and warrant positions, with potential for increased returns if the share price performs well, but also bear the risk of lower proceeds if the share price underperforms the benchmark.

Next Steps

• Receive 11 additional monthly tranches under the Sharing Agreement, commencing approximately 30 days after closing.
• Apply for Admission (listing) of the issued shares and underlying warrant shares on the CBOE.
• Continue to use net proceeds for working capital and general corporate purposes.
• Holders of warrants may exercise their subscription rights for Common Shares at CAD$7.00 per share until November 6, 2028.

Key Dates

Recommendation

The financing provides necessary capital for VERSES AI, which is a positive for its operational stability and growth initiatives in the cognitive computing space. However, the complex, performance-linked nature of the tranches introduces uncertainty regarding the total capital ultimately received and the effective dilution. The 8% brokerage fee also reduces the net proceeds. While the company is securing funding, the market's reaction to the dilution and the variable nature of future tranches warrants a cautious "hold" stance until there is clearer visibility on the company's execution, market adoption of its technology, and the actual proceeds realized from the financing. Investors should monitor the share price performance relative to the benchmark and the impact of future tranches.

Keywords

VERSES AI, VERS, VRSSF, Private Placement, Equity Financing, Warrants, Subscription Agreement, Sharing Agreement, Capital Raise, Cognitive Computing, Agentic Software, SEC Filing, 8-K, Sorbie Bornholm LP, Sorbie Investments LLP, Dilution, CBOE, Canadian Securities Exchange